New award for carbidopa/levodopa immediate-release (IR) tablets with xlcare pharmaceuticals, INC. Ordering period is june 21, 2026 to june 20, 2027 with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0027
- Awardee
-
Xlcare Pharmaceuticals Inc. UEI MEAUS5WHBJJ7
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Carbidopa Levodopa Immediate Release (IR) Tablets Pre-Solicitation · 36E79726R0008 · Posted Dec 10, 2025
- Last date to order 32% complete
- IDV ceiling
- $11,802,604.79
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Xlcare Pharmaceuticals Inc. on June 21, 2026, with a ceiling value of $11,802,604.79 for Carbidopa/Levodopa Immediate-Release tablets. Xlcare Pharmaceuticals Inc. is a minority-owned, economically disadvantaged woman-owned small business.
The contract covers pharmaceutical supply across five federal customers: the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The IDIQ carries a one-year base period through June 20, 2027, with four one-year option periods.
The originating solicitation (36E79726R0008) required offerors to provide an exact drug name as labeled, hold a unique NDC number, and ensure their label be the sole label affixed to the product. The contract covers three formulations—10MG/100MG, 25MG/100MG, and 25MG/250MG immediate release tablets—each available in 100-, 500-, and 1,000-tablet bottle configurations. Carbidopa/Levodopa tablets are distributed through VA and DoD Pharmaceutical Prime Vendor Programs. The NAICS code is 325412 (Pharmaceutical Preparation Manufacturing); the PSC code is 6505 (Drugs and Biologicals). The contract modification incorporates Section 5 of Executive Order 14398, Clause 52.222-90, addressing discrimination and diversity, equity, and inclusion compliance.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0027?
36E79726D0027 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on June 21, 2026.
How much is contract 36E79726D0027 worth?
36E79726D0027's own ceiling is $11,802,605.
Who can order from contract 36E79726D0027?
36E79726D0027 is a single award indefinite delivery contract.
Was contract 36E79726D0027 competed?
The extent of competition for 36E79726D0027 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV